Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Wednesday, November 26, 2025
Tempest’s $8 Million Registered Direct Offering
Tuesday, November 25, 2025
Phrontline’s $60 Million Pre-A+
Zetagen’s $13 Million Series B1
Monday, November 24, 2025
Enlivex’s $212 Million Private Placement
Dayra’s $50 Million Venture Financing
Verrica’s $50 Million Private Placement
MindImmune’s $30 Million Series A
Scilex’s $20 Million Warrant Exercise
Azitra’s $1 Million Private Placement
Thursday, November 21, 2025
BioAtla’s $22 Million Flexible Financing
Cassidy’s $8 Million Seed Round
Thursday, November 20, 2025
Inhibikase’s $100 Million Public Offering
Wednesday, November 19, 2025
Olema’s $190 Million Public Offering
Lifordi’s $112 Million Fund Raise
AI Proteins’s $42 Million Series A
HCW’s $4 Million Warrant Exercise
FibroBiologics’s $4 Million Registered Direct Offering
Tuesday, November 18, 2025
RespireRx’s $45 Million Private Placement
Avanzanite’s $37 Million Series A
Fennec $5 Million Private Placement
Monday, November 17, 2025
J&J’s $3.05 Billion Acquisition of Halda Therapeutics
Nuvalent’s $500 Million Public Offering
Inventiva’s $173 Million Public Offering
Invivyd’s $125 Million Public Offering
Solve’s $120 Million Venture Financing…MoreMore
Artios’s $115 Million Series D…MoreMore
Angiex’x $31 Million Venture Financing
Captain’s $23 Million Venture Financing
Skeletalis’s $8 Million Fund Raise
MitoRx’s $7 Million Pre-Series A
Sunday, November 16, 2025
Sofinnova Partner’s $753 Million Fund Raise
Friday, November 14, 2025
Annexon’s $86 Million Public Offering
Scripta’s $12 Million Fund Raise
Thursday, November 13, 2025
Day One’s $285 Million Acquisition of Mersana
Inventiva’s $150 Million Public Offering
enGene’s $130 Million Public Offering
T-Therapeutics $91 Million Series A
AEON’s $22 Million Private Placement
Wednesday, November 12, 2025
Biohaven’s $175 Million Public Offering
Centessa’s $250 Million Public Offering
Annexon’s $75 Million Public Offering
Eledon’s $50 Million Public Offering
Modulight’s $12 Million Seed Round
ThirdLaw’s $6 Million Seed Round
Tuesday, November 11, 2025
Cogent’s $200 Million Public Offering
INOVIO’s $25 Million Public Offering
PDS’s $11 Million Registered Direct Offering
Salarius’s $7 Million Public Offering
NanoViricides’s $6 Million Registered Direct Offering and Private Placement
Allurion’s $5 Million Private Placement
Monday, November 10, 2025
Galecto’s $285 Million Acquisition of Damora
Vor Bio’s $100 Million Public Offering
Propanc’s $100 Million Private Placement
Friday, November 7, 2025
Halozyme’s $650 Million Debt Financing
Billion to One’s $314 Million IPO
Pelthos’s $18 Million Debt Financing
Pfizer’s Merger with Metsera…More
Thursday, November 6, 2025
Benitec’s $100 Million Registered Direct Offering
4DMT’s $100 Million Pre-Funded Warrants
Palatin’s $16 Million Public Offering
Wednesday, November 5, 2025
Braveheart’s $185 Million Series A
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck